Adapting a Group-Level PrEP Promotion Intervention Trial for Transgender Latinas During the COVID-19 Pandemic
AIDS Education and Prevention · 2022-12 · 34 (6) · 481-495
DOI: 10.1521/aeap.2022.34.6.481 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS Education and Prevention, 2022-12. Verfasst von Scott D Rhodes und 12 weiteren Autor:innen. Beteiligte Einrichtung: Wake Forest University School of Medicine, Winston-Salem, North Carolina. Hauptthemen laut MEDLINE: Transgender Persons, COVID-19, HIV Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NCHHSTP CDC HHS, ACL HHS.
Abstract (Originalsprache)
The COVID-19 pandemic has profoundly affected the conduct of community-based and community-engaged research. Prior to the pandemic, our community-based participatory research partnership was testing ChiCAS, an in-person, group-level behavioral intervention designed to promote uptake of pre-exposure prophylaxis (PrEP), condom use, and medically supervised gender-affirming hormone therapy among Spanish-speaking transgender Latinas. However, the pandemic required adaptations to ensure the safe conduct of the ChiCAS intervention trial. In this article, we describe adaptations to the trial within five domains. Transgender women are disproportionately affected by HIV, and it is essential to find ways to continue research designed to support their health within the context of the COVID-19 pandemic and future infectious disease outbreaks, epidemics, and pandemics. These adaptations offer guidance for ongoing and future community-based and community-engaged research during the COVID-19 pandemic and/or potential subsequent outbreaks (e.g., monkeypox), epidemics, and pandemics, particularly within under-served marginalized and minoritized communities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wake Forest University School of Medicine, Winston-Salem, North Carolina.
- University of North Carolina Greensboro, Greensboro, North Carolina.
- Centers for Disease Control and Prevention, Atlanta, Georgia.
- Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Förderung
- NICHD NIH HHS
- NCHHSTP CDC HHS
- ACL HHS
Zitieren
APA
Rhodes, S. D., Tanner, A. E., Mann-Jackson, L., Alonzo, J., Refugio Aviles, L., Galindo, C. A., Bessler, P. A., Courtenay-Quirk, C., Smart, B. D., Garcia, M., Goldenberg, T., Sucaldito, A. D., & Reboussin, B. A. (2022). Adapting a Group-Level PrEP Promotion Intervention Trial for Transgender Latinas During the COVID-19 Pandemic. AIDS Education and Prevention, 34(6), 481-495. https://doi.org/10.1521/aeap.2022.34.6.481
Vancouver
Rhodes SD, Tanner AE, Mann-Jackson L, Alonzo J, Refugio Aviles L, Galindo CA, et al. Adapting a Group-Level PrEP Promotion Intervention Trial for Transgender Latinas During the COVID-19 Pandemic. AIDS Education and Prevention. 2022;34(6):481-495. doi:10.1521/aeap.2022.34.6.481
BibTeX
@article{Rhodes2022,
author = {Rhodes, Scott D and Tanner, Amanda E and Mann-Jackson, Lilli and Alonzo, Jorge and Refugio Aviles, Lucero and Galindo, Carla A and Bessler, Patricia A and Courtenay-Quirk, Cari and Smart, Benjamin D and Garcia, Manuel and Goldenberg, Tamar and Sucaldito, Ana D and Reboussin, Beth A},
title = {Adapting a Group-Level PrEP Promotion Intervention Trial for Transgender Latinas During the COVID-19 Pandemic},
journal = {AIDS Education and Prevention},
year = {2022},
volume = {34},
number = {6},
pages = {481--495},
doi = {10.1521/aeap.2022.34.6.481}
}
EUVIMED